文献速递骨质疏松与代谢性骨病创伤骨科

利用医疗行政(理赔)数据的观察性骨质疏松药物效果研究中骨折定义的范围综述

Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review.
PubMed 文献 · Osteoporos Int · 2022-05-17

本范围综述检索了2000至2020年加拿大和美国利用理赔数据评估骨质疏松药物骨折有效性或安全性的英文研究,共纳入57项。髋部骨折是最常研究的部位(93%),半数研究未说明数据来源、代码或引用验证论文,各骨折部位的定义异质性大,最常用定义在相应研究中均不足半数使用。作者认为需提高结局报告的透明度,并有必要进一步探索骨折定义对研究结果的影响。

要点

  • 57项利用理赔数据的骨质疏松药物研究中,髋部骨折最常被研究(93%),非典型股骨骨折仅9%。
  • 半数研究(n=29)未指明具体数据源、代码或引用验证论文。
  • 各骨折部位定义异质性大,最常用定义在相应有效性研究中采用率均不足半数。

核心结论

  • 利用理赔数据的骨折结局定义存在模糊性和异质性。
  • 需要提高结局报告的透明度。
  • 有必要进一步探索骨折定义如何影响研究结果。

研究设计与样本

  • 范围综述,检索MEDLINE(Ovid)、Embase(Ovid)、CINAHL(EBSCO)及灰色文献中2000至2020年发表的英文研究。
  • 纳入标准为利用加拿大和美国理赔数据估计骨质疏松药物对髋部、肱骨、桡尺骨、椎体骨折有效性或对非典型股骨骨折安全性的研究。
  • 文献检索、筛选和数据提取由两名评价者独立完成。
  • 共纳入57项研究(52项有效性、3项安全性、2项两者兼有)。

主要发现

  • 髋部骨折是最常研究的部位(93%),其次为肱骨(66%)、椎体(61%)、桡尺骨(59%),非典型股骨骨折占9%。
  • 半数研究(n=29)未指明具体数据源、代码或引用验证论文。
  • 在细节充分的研究中,各部位最常用定义在相应有效性研究中的使用均不足半数:29篇髋部骨折论文中有12种定义,17篇肱骨论文中有8种,13篇桡尺骨论文中有8种,15篇椎体论文中有9种。
  • 4篇非典型股骨骨折论文中有3种定义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Healthcare administrative (claims) data are commonly utilized to estimate drug effects. We identified considerable heterogeneity in fracture outcome definitions in a scoping review of 57 studies that estimated osteoporosis drug effects on fracture risk. Better understanding of the impact of different fracture definitions on study results is needed. PURPOSE: Healthcare administrative (claims) data are frequently used to estimate the real-world effects of drugs. Fracture incidence is a common outcome of osteoporosis drug studies. We aimed to describe how fractures are defined in studies that use claims data. METHODS: We searched MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCO), and gray literature for studies published in English between 2000 and 2020 that estimated fracture effectiveness (hip, humerus, radius/ulna, vertebra) or safety (atypical fracture of the femur, AFF) of osteoporosis drugs using claims data in Canada and the USA. Literature searches, screening and data abstraction were completed independently by two reviewers. RESULTS: We identified 57 eligible studies (52 effectiveness, 3 safety, 2 both). Hip fracture was the most common fracture site studied (93%), followed by humerus (66%), radius/ulna (59%), vertebra (61%), and AFF (9%). Half (n = 29) of the studies did not indicate specific data sources, codes, or cite a validation paper. Of the papers with sufficient detail, heterogeneity in fracture definitions was common. The most common definition within each fracture site was used by less than half of the studies that examined effectiveness (12 definitions in 29 hip fracture papers, 8 definitions in 17 humerus papers, 8 definitions in 13 radius/ulna papers, 9 definitions in 15 vertebra papers), and 3 definitions among 4 AFF papers. CONCLUSION: There is ambiguity and heterogeneity in fracture outcome definitions in studies that leverage claims data. Better transparency in outcome reporting is needed. Future exploration of how fracture definitions impact study results is warranted.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Konstantelos N, Rzepka AM, Burden AM, et al. Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review. Osteoporos Int. 2022. PMID: 35578134. doi:10.1007/s00198-022-06395-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。